Main Article Content

Abstract

Introduction: Les maladies des voies visuelles peuvent être l’expression d’une atteinte de leurs structures propres ou d’une affection des structures cérébrales de voisinage. Elles sont congénitales (malformation) ou acquises (inflammatoire, toxique, tumorale, vasculaire, traumatique, dégénérative). Objectif: Décrire les principales pathologies des voies visuelles au CHU de Brazzaville. Matériels et méthodes: Étude transversale réalisée dans le service d’Ophtalmologie du CHU de Brazzaville sur une période de 5 ans (2011 – 2014). Elle a été faite sur la base de dossiers de patients suivis pour une atteinte d’au moins une voie visuelle (nerf optique, chiasma optique, bandelettes optiques, radiations optiques, cortex visuel). Avaient été exclus de cette enquête les dossiers des patients qui souffraient de glaucome et de papillopathie. Le champ visuel (octopus), le test d’Ishihara, le scanner et/ou l’IRM, la ponction lombaire et les sérologies (Lyme, VIH, TPHA-VDRL) avaient été réalisés chaque fois que cela avait été nécessaire. Résultats : 52 dossiers ont été retenus. Les pathologies étaient représentées par: névrite optique rétrobulbaire (40,38%), séquelles d’accident vasculaire cérébral (36,54%) avec HTA comme facteur de risque dans 100% des cas, adénome hypophysaire (9,61%), séquelles de traumatisme crânien (5,77%), névrite optique toxique due à l’éthambutol (5,77%), gliome du nerf optique (1,93%).
Conclusion: Les pathologies des voies visuelles au CHU de Brazzaville sont essentiellement inflammatoires et vasculaires. Un meilleur suivi de l’HTA peut réduire leur fréquence.

ABSTRACT
Introduction: Diseases of the visual pathways may be an expression of their own structures or of brain neighborhood structures. They can be congenital (malformations) or acquired (inflammatory, toxic, tumor, vascular, traumatic, and degenerative). Objective: To describe the main pathologies of the visual pathways at the University Teaching Hospital of Brazzaville (UHB). Materials and Methods: Cross-sectional study conducted in the Ophthalmology department of the UHB over a period of 5 years (2011 - 2014). It was made on the basis of records of patients followed for pathology of at least a visual pathway (optic nerve, optic chiasm, optic radiations, optical radiations, visual cortex). Were excluded from this survey records of patients suffering from glaucoma and papillopathy. The visual field (Octopus), the Ishihara test, CT scan and / or MRI, lumbar puncture and serologies (Lyme, HIV, TPHA-VDRL) were made whenever was necessary. Results: 52 records were found. The pathologies were represented by: retrobulbar optic neuritis (40.38%), sequellae of stroke (36.54%) with high blood pressure as a risk factor in 100% of cases, pituitary adenoma (9.61%), sequellae of head trauma (5.77%), optical neuritis toxic due to ethambutol (5.77%), and glioma of the optic nerve (1.93%).
Conclusion: The pathologies of the visual pathways at the UHB are essentially inflammatory and vascular. Better monitoring of high blood pressure can reduce their incidence.

Article Details

How to Cite
Atipo Tsiba, P., Eballe, A., Dohvoma, V., Ebana Mvogo, s, Diomandé, I., Noa, G., Nomo, A., Nomo, C., & Tapsoba, Y. (2016). Etiologies des Affections des Voies Visuelles au CHU de Brazzaville. HEALTH SCIENCES AND DISEASE, 17(4). https://doi.org/10.5281/hsd.v17i4.747

References

  1. Tanaka R, Yotsumoto Y. Networks extending across dorsal and ventral visual pathways correlate with trajectory perception. J Vis. 2016;16(6):21.
  2. Zhou H, Zhao S, Yin D, Chen X, Xu Q, Chen T et al. Optic neuritis: a 5-year follow-up study of Chinese patients based on aquaporin-4 antibody status and ages. J Neurol. 2016 May 9. [Epub ahead of print].
  3. Costello F.Vision Disturbances in Multiple Sclerosis. Semin Neurol.2016;36(2):185-95.
  4. Qian Z, Kang H, Tang K, Jiang C, Wu Z, Li Y et al. Assessment of Risk of Aneurysmal Rupture in Patients with Normotensives, Controlled Hypertension, and Uncontrolled Hypertension. J Stroke Cerebrovasc Dis. 2016 Apr 14. [Epub ahead of print]
  5. Baxter R, Lewis E, Fireman B, DeStefano F, Gee J, Klein NP. Case-centered Analysis of Optic Neuritis After Vaccines. Clin Infect Dis. 2016 Apr 10. [Epub ahead of print].
  6. Laible M, Jarius S, Mackensen F, Schmidt-Bacher A, Platten M, Haas J et al. Adding Papillomacular Bundle Measurements to Standard Optical Coherence Tomography Does Not Increase Sensitivity to Detect Prior Optic Neuritis in Patients with Multiple Sclerosis. PLoS One. 2016 May 12;11(5):e0155322.
  7. Ziganshin RH, Ivanova OM, Lomakin YA, Belogurov AA Jr, Kovalchuk SI, Azarkin IV et al. The pathogenesis of demyelinating form of Guillain-Barre syndrome: proteo-peptidomic and immunological profiling of physiological fluids. Mol Cell Proteomics. 2016 May 3. [Epub ahead of print].
  8. De Paulis D, Nicosia G, Taddei G, Di Vitantonio H, Gallieni M, Del Maestro M et al. Intracranial aneurysms and optic glioma - an unusual combination: a case report. J Med Case Rep. 2016;10(1):78.
  9. Traber GL, Pangalu A, Neumann M, Costa J, Weller M, Huna-Baron R et al. Malignant optic glioma - the spectrum of disease in a case series. Graefes Arch Clin Exp Ophthalmol. 2015;253(7):1187-94.
  10. Grzybowski A, Zülsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015;93(5):402-10.
  11. Yang HK, Park MJ, Lee JH, Lee CT, Park JS, Hwang JM. Incidence of toxic optic neuropathy with low-dose ethambutol. Int J Tuberc Lung Dis. 2016;20(2):261-4.
  12. Chen SC, Lin MC, Sheu SJ. Incidence and prognostic factor of ethambutol-related optic neuropathy: 10-year experience in southern Taiwan. Kaohsiung J Med Sci. 2015;31(7):358-62.
  13. Cao Y, Wang F, Liu Z, Jiao B. Effects of preoperative bromocriptine treatment on prolactin-secreting pituitary adenoma surgery. Exp Ther Med. 2016;11(5):1977-1982.
  14. Singh H, Essayed WI, Cohen-Gadol A, Zada G, Schwartz TH. Resection of pituitary tumors: endoscopic versus microscopic. J Neurooncol. 2016 May 9. [Epub ahead of print].
  15. Yu B, Ji N, Ma Y, Yang B, Kang P, Luo F. Clinical characteristics and risk factors for headache associated with non-functioning pituitary adenomas. Cephalalgia. 2016 May 6. [Epub ahead of print].
  16. Atipo-Tsiba PW, Borruat FX. Traumatic dysfunction of the optic chiasm. Klin Monbl Augenheilkd. 2003;220(3):138-41.
  17. Wang Y, Lu Z, Sun S, Yang Y, Zhang B, Kang Z et al. Risk Factors, Topographic Patterns and Mechanism Analysis of Intracranial Atherosclerotic Stenosis Ischemic Stroke. Int J Neurosci. 2016 May. [Epub ahead of print].
  18. Qiu M, Sato S, Zheng D, Wang X, Carcel C, Hirakawa Y et al. Admission Heart Rate Predicts Poor Outcomes in Acute Intracerebral Hemorrhage: The Intensive BloodPressure Reduction in Acute Cerebral Hemorrhage Trial Studies. Stroke. 2016 May 10. [Epub ahead of print].
  19. Baldo MP, Zaniqueli DA, Magalhães P, Capingana DP, Silva AB, Mill JG. Gender-specific determinants of blood pressure elevation in Angolan adults. Blood Press. 2016 May 13. [Epub ahead of print].
  20. Bae DH, Choi KS, Yi HJ, Chun HJ, Ko Y, Bak KH. Cerebral Infarction after Traumatic Brain Injury: Incidence and Risk Factors. Korean J Neurotrauma. 2014;10(2):35-40.
  21. Wang B, Moon SJ, Olivero WC, Wang H. Cortical blindness as a rare presentation of cerebral venous thrombosis. J Surg Case Rep. 2013 May 9;2013(5). pii: rjt035. doi: 10.1093/jscr/rjt035.
  22. Chokron S. Cortical blindness. J Fr Ophtalmol. 2014;37(2):166-72.

Most read articles by the same author(s)

1 2 > >> 

Similar Articles

You may also start an advanced similarity search for this article.